303 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urinary Bladder Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Conditions: Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate low dose;   Drug: Solifenacin succinate high dose
2 Recruiting Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns
Conditions: Multiple Sclerosis;   Urinary Bladder Diseases
Intervention: Behavioral: Systematic Screening and Education Regimen
3 Not yet recruiting SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I
Conditions: Urinary Bladder Neoplasms;   Urologic Neoplasms;   Urogenital Neoplasms;   Neoplasms;   Neoplasms by Site;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
4 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
5 Recruiting Investigating Three-Dimensional Versus Two-Dimensional Imaging in Laparoscopic Cholecystectomies
Condition: Gall Bladder Disease
Intervention: Device: Laparoscopic visual system
6 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
7 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
8 Recruiting Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)
Condition: Non Muscle Invasive Bladder Cancer
Interventions: Device: TC-3 Gel;   Other: Standard of care MMC mixed with water
9 Recruiting A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)
Condition: Non Muscle Invasive Bladder Cancer
Intervention: Device: TC-3 hydrogel
10 Not yet recruiting Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study;   Other: laboratory biomarker analysis
11 Recruiting Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
Condition: Bladder Cancer
Interventions: Other: Computed Tomography Urography (CTU);   Other: Intravenous Urography (IVU)
12 Recruiting Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
Conditions: Prostate Cancer;   Bladder Cancer;   Kidney Cancer
Intervention: Drug: Ferumoxytol
13 Not yet recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
14 Recruiting Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Other: Observation
15 Recruiting Familial and Atypical Urothelial Cancer Registry
Conditions: Urothelial Cancer;   Renal Pelvis Cancer;   Ureter Cancer;   Bladder Cancer
Interventions: Other: saliva sample and questionaire;   Other: saliva sample, questionaire
16 Unknown  Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
Condition: Interstitial Cystitis
Intervention: Procedure: Acupuncture
17 Recruiting Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin
Conditions: Invasive Bladder Cancer;   Bladder Cancer
Intervention: Drug: Gemcitabine and fractionated cisplatin (combination treatment)
18 Recruiting Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study
Conditions: Chronic Pelvic Pain Syndrome;   Bladder Pain Syndrome
Interventions: Drug: doxycycline;   Drug: placebo
19 Recruiting Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
Conditions: Overactive Bladder;   Bladder Cancer;   Synergo
Intervention: Other: Questionnaires, anticholinergic treatment, urodynamic study
20 Recruiting Gene Expression in the Overactive Bladder in Children
Conditions: Overactive Bladder;   Children
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years